Results 71 to 80 of about 932 (190)

MILDRONATE POTENTIAL FOR CORRECTING COGNITIVE DYSFUNCTION IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION

Российский кардиологический журнал, 2011
The study aimed to assess the effects of long-term and course mildronate therapy (500 mg/d) on cognitive function in elderly patients with arterial hypertension (AH) and cognitive dysfunction.
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, E. V. Chumachok, A. A. Ledyaeva, V. V. Tsoma   +7 more
doaj  

The change of the concomitant systems of POL, AOS and hemostasis in vascular complications forming under the experimental diabetes mellitus and their antioxidant correction

RUDN Journal of Medicine, 2009
In ESD experimental diabetes mellitus on the background of vitamin E and mildronate introduction, an activation of amino acid system: SOD and catalaza and decrease of MDA content in erythrocytes.
S G Dzugkoev, L G Khetagurova, F S Dzugkoeva   +2 more
doaj  

[Mildronate in geriatric patients with cardiac failure].

Terapevticheskii arkhiv, 2006
To study efficacy of mildronate in the treatment of elderly patients with cardiac failure (CF).A total of 91 patients with chronic CF (NYHA FC I-III) entered the study. The study group of 63 patients received standard therapy for a month and mildronate in a dose 750 mg/day. The control group of 28 patients was treated conventionally.
I, Kalvinsh, A, Visokinskas, G, Bagdonas, Iu, Knasene, V, Lesaukaite, Iu, Matsiyauskene   +5 more
openaire   +1 more source

MILDRONATE POTENTIAL IN PATIENTS WITH CARDIOVASCULAR DISEASE

Российский кардиологический журнал, 2010
.
V. P. Mikhin, F. E. Khlebodarov
openaire   +1 more source

Myocardial cytoprotection and ischemic myocardial dysfunction correction in stable angina patients after transluminal balloon angioplasty or coronary artery stenting

Российский кардиологический журнал, 2006
The results of myocardial cytoprotection with mildronate and trimethazidine (Preductal MB) in stable angina patients with left ventricular (LV) myocardial dysfunction, including hibernation, are presented.
I. G. Gordeev, V. A. Lusov, E. A. Bekchiu, N. A. Volov, E. E. Ilina, A. Yu. Lebedeva   +5 more
doaj  

COMPARING MOLECULAR EFFECTS OF VARIOUS CYTOPROTECTORS IN COMPLEX THERAPY OF CORONARY HEART DISEASE

Российский кардиологический журнал, 2009
The molecular effects of trimetazidine and mildronate were investigated in patients with stable effort angina, Functional Class (FC) I-III. The comparison criteria included blood activity and concentrations of the main products of free-radical oxidation ...
E. A. Kartashova
doaj  

Combat high : a sobering history of drug use in wartime [PDF]

Stimulants have long been known to enhance combat performance, keeping personnel awake, alert, and hence alive after prolonged periods of fatigue. Intoxicants also “take the edge off” war, enabling soldiers to cope with the traumas of the battlefield ...
Kamieński, Łukasz
core  

[Therapeutic efficacy of mildronate in pulmonary diseases].

Likars'ka sprava, 2006
Immuno-corrective action of the medication has been proved by analyzing Mildronate administration in 64 patients with bronchial asthma and secondary immunodeficiency. Stimulation of sell component and inhibition of humoral component of the immunity system, improvement of central hemodynamics and normalization of the hemopoiesis system to some extent ...
V P, Mkrtchian, V A, Orlov
openaire   +1 more source

Functional nitric oxide conjugate systems state/restored heart thiols of rats in modeling isadrine-pituitrin’s myocardial infarction using metabolite-tropic cardioprotector “Angiolin” [PDF]

, 2017
Background: According to modern researches, endothelial dysfunction (ED) is one of the primary pathogenetic elements of cardiovascular diseases (myocardial infarction [MI], ischemic heart diseases, cerebral ischemic stroke, atherosclerosis, arterial ...
Avramenko, Nikolay A., Belenichev, Igor F., Bidnenko, Alexander S., Bukhtiyarova, Nina V., Kucherenko, Lyudmila I., Mazur, Ivan A., Nagornaya, Elena A.   +6 more
core   +1 more source

CYTOPROTECTOR ROLE IN THE MANAGEMENT OF ARTERIAL HYPERTENSION TREATED WITH ENALAPRIL

Российский кардиологический журнал, 2009
The study investigated the effects of cardiac cytoprotectors – mildronate and trimetazidine, combined with ACE therapy, on lipid peroxidation product levels, endothelial function, circadian blood pressure (BP) profile, left ventricular myocardium, and ...
F. E. Khebodarov, V. P. Mikhin
doaj